Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Recursion Pharmaceuticals

Recursion Pharmaceuticals
2013 FOUNDED
PRIVATE STATUS
21-30 EMPLOYEES
Debt LATEST DEAL TYPE
$20.5M LATEST DEAL AMOUNT
31 INVESTORS
Description

Provider of a drug discovery platform designed to interrogate complex biological interactions for drug re-purposing. The company's drug discovery platform uses biological tools to build cellular disease models, enabling biologists to query and understand the results of phenotypic screens, drug screens and target discovery screens with immediate access to raw images and underlying data.

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Primary Office
  • 630 South Komas Drive
  • Suite 300
  • Salt Lake City, UT 84108
  • United States

+1 (385) 000-0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Recursion Pharmaceuticals’s full profile, request a free trial.

Recursion Pharmaceuticals Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Debt - General 05-Jun-2018 $20.5M 00000 Completed Pre-Clinical Trials
4. Early Stage VC (Series B) 03-Oct-2017 0000 000.00 00000 Completed Pre-Clinical Trials
3. Early Stage VC (Series A) 07-Feb-2017 0000 000.00 0000 Completed Startup
2. Grant 25-Feb-2015 $1.5M $170K Completed Startup
1. Seed Round 15-Aug-2014 $170K $170K Completed Startup
To view this company’s complete deal history including valuation and funding, request access »

Recursion Pharmaceuticals Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate ($) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion
Price
% Owned
Series B 00,000,000 00.000000 00.00 00.00 00.00 00 00.00 00.000
Series A1 0,000,000 00.000000 00.00 00.00 00.00 00 00.00 0.000
Series A 20,052,268 $0.000010 $0.09 $1.07 $1.07 1x $1.07 28.53%
To view this company’s complete Cap Table, request access »

Recursion Pharmaceuticals Investors (31)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
Amplify Partners Venture Capital Minority 000 0000 000000 0
Charles River Ventures Venture Capital Minority 000 0000 000000 0
Menlo Ventures Venture Capital Minority 000 0000 000000 0
Mubadala Investment Company Sovereign Wealth Fund Minority 000 0000 000000 0
Two Sigma Ventures Venture Capital Minority 000 0000 000000 0
You’re viewing 5 of 31 investors. Get the full list »

Recursion Pharmaceuticals Executive Team (13)

Name Title Board
Seat
Contact
Info
Christopher Gibson Ph.D Co-Founder, Chief Executive Officer & Board Member
John Pereira Chief Operating Officer & Chief Marketing Officer
Tina Larson Chief Operating Officer
Blake Borgeson Ph.D Chief Technology Officer, Board Member and Co-Founder
Martin Brenner Ph.D Chief Scientific Officer
You’re viewing 5 of 13 executives. Get the full list »

Recursion Pharmaceuticals Board Members (10)

Name Representing Role Since Contact
Info
Alaa Halawa Mubadala Investment Company Board Observer 000 0000
Blake Borgeson Ph.D Recursion Pharmaceuticals Chief Technology Officer, Board Member and Co-Founder 000 0000
Christopher Gibson Ph.D Recursion Pharmaceuticals Co-Founder, Chief Executive Officer & Board Member 000 0000
Dean Li Ph.D Recursion Pharmaceuticals Board Observer & Co-Founder 000 0000
James Hardiman Data Collective Board Observer 000 0000

1 Former Board Member

You’re viewing 5 of 10 board members. Get the full list »